113 Followers on Owler

Amicus

is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Amicus

is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read more
Amicus President & CEO: Bradley L Campbell

President & CEO

Bradley L Campbell

CEO Approval Rating

82/100

2002

PublicIndependent CompanyNASDAQFOLD

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
$528.3M
Employees
480
Funding
$1.3B
Acquisitions
3

News

Conference Presentation
Feb 27, 2025
Marketscreener
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025

Amicus Competitors

1Sanofi
2Takeda Pharmaceutical
3Idorsia
4Protalix
5Freeline
6Sangamo
74DMT
8Bayer
9Astellas
10Roche
Unlock 22 + competitors

Trending Companies